Semaglutide is now approved for reducing the risk for worsening kidney disease and cardiovascular death in adults with ...

Both of these GLP-1 drugs were originally designed for diabetes, but their benefits keep expanding — KSTP health expert Dr.

Ozempic and other GLP-1 agonists are helping millions with weight loss but concerns grow over their long-term effects. Recent ...

Discover the groundbreaking studies revealing how exercise can control hunger cravings and impact weight loss... but how it ...